SCHEMBL31454862

SCHEMBL31454862

COc1ccc2c(CO)cc(=O)oc2c1C(=O)N1CCCc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.59
▸ LMNA P02545 4/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ MAPT P10636 4/20 0.59
▸ GAA P10253 3/20 0.59
▸ HPGD P15428 2/20 0.59
▸ NPSR1 Q6W5P4 2/20 0.59
▸ HTT P42858 1/20 0.59
▸ CYP2C19 P33261 2/20 0.54
▸ PDE4A P27815 1/20 0.53
▸ PDE4B Q07343 1/20 0.53
▸ PDE4C Q08493 1/20 0.53
▸ PDE4D Q08499 1/20 0.53
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ MCL1 Q07820 1/20 0.50
▸ TSHR P16473 4/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454924 0.94 ALDH1A1 (0.68) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454893 0.91 ALDH1A1 (0.60) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454858 0.90 ALDH1A1 (0.58) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454923 0.88 CYP2C19 (0.55) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454855 0.88 CYP2C19 (0.65) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454907 0.85 CYP2C19 (0.54) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454890 0.85 ALDH1A1 (0.66) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454873 0.84 ALDH1A1 (0.67) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454840 0.83 ALDH1A1 (0.59) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL31454905 0.82 ALDH1A1 (0.61) ALDH1A1LMNAKDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042896-A1 DNA TOPOISOMERASE IIβ INHIBITORS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2025-02-27 — — WO disclosed
Send feedback